Technology areas: Biotechnology & Pharmaceuticals • Semiconductors, Circuits & Optics
7 pending office actions • 6 art units • 7 examiners • 0 of 7 (0%) have an AI response strategy ready
Teikyo University has 6 pending office actions in Biotechnology & Pharmaceuticals. Those matters involve 6 distinct examiners and 5 distinct art units, indicating that the docket is spread across examiners while remaining somewhat concentrated by technical group.
WRIGHT, ANDREW RUSSELL is the busiest listed examiner, with 1 pending action. No examiner carries a larger identified share of the docket, so response planning should be organized matter by matter. The 5-art-unit distribution also supports reviewing claim scope and technical framing separately for each assigned group rather than relying on a single prosecution position.
Based on the USPTO statutory response window for each pending office action. 1 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (14%) |
| §112 only | 2 (29%) |
| Multi-statute (no §101) | 4 (57%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WRIGHT, ANDREW RUSSELL | 1 | 68.8% | +40.0% |
| SHERMAN, STEPHEN G | 1 | 82.3% | +16.8% |
| HABTE, KAHSAY | 1 | 84.9% | +7.5% |
| MONSUR, NASIMA | 1 | 78.5% | +26.0% |
| KOROTCHKINA, LIOUBOV G | 1 | 29.0% | +64.1% |
| AFREMOVA, VERA | 1 | 50.5% | +29.4% |
| NGUYEN, QUANG | 1 | 37.9% | +52.6% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18852886 | BLOOD VESSEL SEGMENT DISCRIMINATION SYSTEM, BLOOD VESSEL SEGMENT DISCRIMINATION METHOD, AND PROGRAM | SHERMAN, STEPHEN G | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 5 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17260418 | LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE | NGUYEN, QUANG | 88d overdue |
| 18877741 | SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD | WRIGHT, ANDREW RUSSELL | — |
| 18846479 | RETINAL VASODILATOR AND PHARMACEUTICAL COMPOSITION | HABTE, KAHSAY | — |
| 17924704 | THERMOSTABLE GLUCOCEREBROSIDASE | KOROTCHKINA, LIOUBOV G | — |
| 17795995 | SCREENING CULTURE MEDIUM AND SCREENING METHOD | AFREMOVA, VERA | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 6 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17260418 | LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE | NGUYEN, QUANG | 88d overdue |
| 18877741 | SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD | WRIGHT, ANDREW RUSSELL | — |
| 18852886 | BLOOD VESSEL SEGMENT DISCRIMINATION SYSTEM, BLOOD VESSEL SEGMENT DISCRIMINATION METHOD, AND PROGRAM | SHERMAN, STEPHEN G | — |
| 18724864 | PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION SYSTEM, PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION METHOD, AND PROGRAM | MONSUR, NASIMA | — |
| 17924704 | THERMOSTABLE GLUCOCEREBROSIDASE | KOROTCHKINA, LIOUBOV G | — |
| 17795995 | SCREENING CULTURE MEDIUM AND SCREENING METHOD | AFREMOVA, VERA | — |
| Art Unit | Apps |
|---|---|
| 1653 | 2 |
| 2872 | 1 |
| 2621 | 1 |
| 1624 | 1 |
| 2858 | 1 |
| 1631 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18877741 | SURGICAL MICROSCOPE SYSTEM, AUXILIARY IMAGING DEVICE, AND SURGICAL FIELD IMAGING METHOD | WRIGHT, ANDREW RUSSELL | 2872 | §102§103§112 | Non-Final OA | — | Pending | Dec 20, 2024 |
| 18852886 | BLOOD VESSEL SEGMENT DISCRIMINATION SYSTEM, BLOOD VESSEL SEGMENT DISCRIMINATION METHOD, AND PROGRAM | SHERMAN, STEPHEN G | 2621 | §112 | Final Rejection | — | Pending | Sep 30, 2024 |
| 18846479 | RETINAL VASODILATOR AND PHARMACEUTICAL COMPOSITION | HABTE, KAHSAY | 1624 | §102§112 | Non-Final OA | — | Pending | Sep 12, 2024 |
| 18724864 | PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION SYSTEM, PHOTOVOLTAIC MODULE ABNORMALITY DETERMINATION METHOD, AND PROGRAM | MONSUR, NASIMA | 2858 | §112 | Final Rejection | — | Pending | Jun 27, 2024 |
| 17924704 | THERMOSTABLE GLUCOCEREBROSIDASE | KOROTCHKINA, LIOUBOV G | 1653 | §103§112 | Non-Final OA | — | Pending | Nov 11, 2022 |
| 17795995 | SCREENING CULTURE MEDIUM AND SCREENING METHOD | AFREMOVA, VERA | 1653 | §101§103§112 | Final Rejection | — | Pending | Jul 28, 2022 |
| 17260418 | LIPID PARTICLE CONTAINING A-TYPE CpG OLIGODEOXYNUCLEOTIDE | NGUYEN, QUANG | 1631 | §102§103 | Non-Final OA | 88d overdue | Pending | Jan 14, 2021 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialTeikyo University has 7 pending office actions as of October 2026, spread across 6 art units and 7 examiners.
Andrew Russell Wright has the most, with 1 of Teikyo University's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
